The global botanical drug market is anticipated to grow at a considerable CAGR of 7.2% during the forecast. Product innovations coupled up with leading advancements in the botanical drug are anticipated to drive the market in the coming years. For instance, in January 2022, Synergy Flavors, Inc., has extended its R&D laboratories and other collaborative spaces at its Wauconda, Illinois headquarters. This expansion of the company is considered as a part of an organic growth plan to keep up with the high-growing and collaboration needs of both staff and customers.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/botanical-drug-market
In August 2020, Sun pharmaceuticals launched Flugard tablets at a very economical price of $0.46 for the treatment of mild to moderate cases of COVID-19 in India; along with this the company had also initiated a phase II clinical trial on AQCH, a phytopharmaceutical (plant-derived) drug for the treatment of COVID-19.
The rise in diseases across the globe is considered as a major driver for the growth in the botanical drug market. Botanical medications are made from plants that have therapeutic properties. Algae and vegetable components, along with microscopic fungus, are found in botanical medications that support in providing the finest treatment. Botanical and plant-derived medications are used to treat a variety of conditions, including CNS disorders, infectious diseases, cardiovascular diseases, and respiratory diseases. Additionally, botanical and plant-derived medications come in a variety of formats, including pills, tablets, and injections. Plant-derived medications include atropine, aescin, and berberine.
Global Botanical Drug Market Report Segment
By Source
- Plants
- Algae
- Macroscopic fungi
By Dosage form
- Tablets
- Injection
- Pills
By Therapeutic application
- Central Nervous System
- Cardiovascular Diseases
- Respiratory Diseases
- Others
A full report of Botanical Drug Market is available at: https://www.omrglobal.com/industry-reports/botanical-drug-market
Botanical Drug Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Abbott
- Bayer AG
- Boehringer Ingelheim International GmbH.
- Bristol-Mayers Squibb Co.
- Cardax, Inc.
- Hutchmed
- Chong Kun Dang pharmaceutical Corp.
- Eli Lilly and Co.
- Galapagos NV
- GlaxoSmithKline plc
- Glenmark
- HeteroGeneity, LLC
- Indena S.p.A.
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
Visit more report at
https://www.linkedin.com/pulse/scaffold-technology-market-size-trends-latest-arti-vishwakarma-mlsof/
